Global Nucleic Acids for Molecular Diagnosis Market 2025 by Company, Regions, Type and Application, Forecast to 2031

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Nucleic Acids for Molecular Diagnosis by Type
  • 1.3.1 Overview: Global Nucleic Acids for Molecular Diagnosis Market Size by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Type in 2024
  • 1.3.3 DNA Series
  • 1.3.4 RNA Series
• 1.4 Global Nucleic Acids for Molecular Diagnosis Market by Application
  • 1.4.1 Overview: Global Nucleic Acids for Molecular Diagnosis Market Size by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Infectious Diseases
  • 1.4.3 Early Cancer Screening
  • 1.4.4 Blood Screening
  • 1.4.5 Genetic Diseases
  • 1.4.6 Genome Sequencing
  • 1.4.7 Other
• 1.5 Global Nucleic Acids for Molecular Diagnosis Market Size & Forecast
• 1.6 Global Nucleic Acids for Molecular Diagnosis Market Size and Forecast by Region
  • 1.6.1 Global Nucleic Acids for Molecular Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
  • 1.6.2 Global Nucleic Acids for Molecular Diagnosis Market Size by Region, (2020-2031)
  • 1.6.3 North America Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
  • 1.6.4 Europe Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
  • 1.6.5 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
  • 1.6.6 South America Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)
  • 1.6.7 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size and Prospect (2020-2031)

2 Company Profiles

• 2.1 Danaher Corporation
  • 2.1.1 Danaher Corporation Details
  • 2.1.2 Danaher Corporation Major Business
  • 2.1.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.1.4 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Danaher Corporation Recent Developments and Future Plans
• 2.2 Merck KGaA
  • 2.2.1 Merck KGaA Details
  • 2.2.2 Merck KGaA Major Business
  • 2.2.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.2.4 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 Merck KGaA Recent Developments and Future Plans
• 2.3 Eurofins Scientific SE
  • 2.3.1 Eurofins Scientific SE Details
  • 2.3.2 Eurofins Scientific SE Major Business
  • 2.3.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.3.4 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Eurofins Scientific SE Recent Developments and Future Plans
• 2.4 Thermo Fisher Scientific Inc.
  • 2.4.1 Thermo Fisher Scientific Inc. Details
  • 2.4.2 Thermo Fisher Scientific Inc. Major Business
  • 2.4.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.4.4 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
• 2.5 Agilent Technologies, Inc.
  • 2.5.1 Agilent Technologies, Inc. Details
  • 2.5.2 Agilent Technologies, Inc. Major Business
  • 2.5.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.5.4 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 Agilent Technologies, Inc. Recent Developments and Future Plans
• 2.6 Kaneka Eurogentec S.A.
  • 2.6.1 Kaneka Eurogentec S.A. Details
  • 2.6.2 Kaneka Eurogentec S.A. Major Business
  • 2.6.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.6.4 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 Kaneka Eurogentec S.A. Recent Developments and Future Plans
• 2.7 Aji Bio-Pharma
  • 2.7.1 Aji Bio-Pharma Details
  • 2.7.2 Aji Bio-Pharma Major Business
  • 2.7.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.7.4 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Aji Bio-Pharma Recent Developments and Future Plans
• 2.8 L.G.C Biosearch Technologies
  • 2.8.1 L.G.C Biosearch Technologies Details
  • 2.8.2 L.G.C Biosearch Technologies Major Business
  • 2.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.8.4 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 L.G.C Biosearch Technologies Recent Developments and Future Plans
• 2.9 Integrated DNA Technologies
  • 2.9.1 Integrated DNA Technologies Details
  • 2.9.2 Integrated DNA Technologies Major Business
  • 2.9.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.9.4 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 Integrated DNA Technologies Recent Developments and Future Plans
• 2.10 Bio-synthesis Inc.
  • 2.10.1 Bio-synthesis Inc. Details
  • 2.10.2 Bio-synthesis Inc. Major Business
  • 2.10.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.10.4 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Bio-synthesis Inc. Recent Developments and Future Plans
• 2.11 metabion
  • 2.11.1 metabion Details
  • 2.11.2 metabion Major Business
  • 2.11.3 metabion Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.11.4 metabion Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 metabion Recent Developments and Future Plans
• 2.12 QIAGEN
  • 2.12.1 QIAGEN Details
  • 2.12.2 QIAGEN Major Business
  • 2.12.3 QIAGEN Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.12.4 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 QIAGEN Recent Developments and Future Plans
• 2.13 Hongene
  • 2.13.1 Hongene Details
  • 2.13.2 Hongene Major Business
  • 2.13.3 Hongene Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.13.4 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.13.5 Hongene Recent Developments and Future Plans
• 2.14 Synthgene
  • 2.14.1 Synthgene Details
  • 2.14.2 Synthgene Major Business
  • 2.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Product and Solutions
  • 2.14.4 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2020-2025)
  • 2.14.5 Synthgene Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Nucleic Acids for Molecular Diagnosis Revenue and Share by Players (2020-2025)
• 3.2 Market Share Analysis (2024)
  • 3.2.1 Market Share of Nucleic Acids for Molecular Diagnosis by Company Revenue
  • 3.2.2 Top 3 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
  • 3.2.3 Top 6 Nucleic Acids for Molecular Diagnosis Players Market Share in 2024
• 3.3 Nucleic Acids for Molecular Diagnosis Market: Overall Company Footprint Analysis
  • 3.3.1 Nucleic Acids for Molecular Diagnosis Market: Region Footprint
  • 3.3.2 Nucleic Acids for Molecular Diagnosis Market: Company Product Type Footprint
  • 3.3.3 Nucleic Acids for Molecular Diagnosis Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Nucleic Acids for Molecular Diagnosis Consumption Value and Market Share by Type (2020-2025)
• 4.2 Global Nucleic Acids for Molecular Diagnosis Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

• 5.1 Global Nucleic Acids for Molecular Diagnosis Consumption Value Market Share by Application (2020-2025)
• 5.2 Global Nucleic Acids for Molecular Diagnosis Market Forecast by Application (2026-2031)

6 North America

• 6.1 North America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
• 6.2 North America Nucleic Acids for Molecular Diagnosis Market Size by Application (2020-2031)
• 6.3 North America Nucleic Acids for Molecular Diagnosis Market Size by Country
  • 6.3.1 North America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
  • 6.3.2 United States Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 6.3.3 Canada Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 6.3.4 Mexico Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)

7 Europe

• 7.1 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
• 7.2 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
• 7.3 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country
  • 7.3.1 Europe Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
  • 7.3.2 Germany Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 7.3.3 France Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 7.3.4 United Kingdom Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 7.3.5 Russia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 7.3.6 Italy Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)

8 Asia-Pacific

• 8.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
• 8.2 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
• 8.3 Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Region
  • 8.3.1 Asia-Pacific Nucleic Acids for Molecular Diagnosis Consumption Value by Region (2020-2031)
  • 8.3.2 China Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 8.3.3 Japan Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 8.3.4 South Korea Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 8.3.5 India Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 8.3.6 Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 8.3.7 Australia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)

9 South America

• 9.1 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
• 9.2 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
• 9.3 South America Nucleic Acids for Molecular Diagnosis Market Size by Country
  • 9.3.1 South America Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
  • 9.3.2 Brazil Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 9.3.3 Argentina Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)

10 Middle East & Africa

• 10.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Type (2020-2031)
• 10.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Application (2020-2031)
• 10.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country
  • 10.3.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis Consumption Value by Country (2020-2031)
  • 10.3.2 Turkey Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 10.3.3 Saudi Arabia Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)
  • 10.3.4 UAE Nucleic Acids for Molecular Diagnosis Market Size and Forecast (2020-2031)

11 Market Dynamics

• 11.1 Nucleic Acids for Molecular Diagnosis Market Drivers
• 11.2 Nucleic Acids for Molecular Diagnosis Market Restraints
• 11.3 Nucleic Acids for Molecular Diagnosis Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Nucleic Acids for Molecular Diagnosis Industry Chain
• 12.2 Nucleic Acids for Molecular Diagnosis Upstream Analysis
• 12.3 Nucleic Acids for Molecular Diagnosis Midstream Analysis
• 12.4 Nucleic Acids for Molecular Diagnosis Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source